This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Patent-pending Fry Cartons are made from Pactiv Evergreen’s Sentinel Paperboard, providing a fully integrated packaging solution to foodservice operators.
For companies involved in pharmaceutical packaging, 2018 looks like it will be a year of scrambling to meet new regulations on serialization, safety and security, while at the same time responding to market demands for personalized care and generational requirements.
Driven by increasingly complex supply chains, a lack of enforcement capacity, the expansion of ecommerce and more sophisticated counterfeiters and counterfeiting methods, the FDA estimates that approximately 10% of all pharmaceuticals currently sold globally are illicit.
The medicine or device may be a home-run product, but if consumers aren’t using the product correctly, it has little chance of success. And if the consumers cannot even open the package to get to the product inside, it has zero chance.